An MIBG scintiscan is an imaging test that uses a radioactive substance (called a tracer) and a special scanner to find or confirm the presence of pheochromocytoma and neuroblastoma, which are tumors of specific types of nervous tissue.

See also: Nuclear scan

Adrenal medullary imaging; Meta-iodobenzylguanidine scintiscan

A radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine) is injected into a vein. This compound attaches to specific tumor cells.

Later that day (or the next day) you lie on a table that is positioned under the arm of the scanner. The abdomen is scanned. You may be asked to return for repeated scans for 1 - 3 days. Each scan takes 1 - 2 hours.

Before or during the test, you may be given an iodine solution to prevent the thyroid from absorbing too much of the radioisotope.

You must sign an informed consent form. You will be asked to wear a hospital gown. However, loose-fitting clothing may be allowed. Remove jewelry or metal objects before each scan.

There is a sharp needle prick when the material is injected. The table may be cold or hard. You must lie still during the scan.

This test is done to confirm pheochromocytoma or neuroblastoma.

Images

MIBG injection

Thyroid enlargement - scintiscan

Next Section

MIBG scintiscan Results

Review Date: 11/21/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)